BCHE Antibody

• Background:

  Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.

• NCBI Gene ID:

  590

• Swiss Prot:

  P06276

• Host:

  Rabbit

• Reactivity:

  Human, Mouse, Rat

• Immunogen:

  Recombinant fusion protein containing a sequence corresponding to amino acids 29-270 of human BCHE (NP_000046.1) .

• Clonality:

  Polyclonal

• Conjugation:

  Unconjugated

• Type:

  Primary Antibodies

• Field of Research:

  Neuroscience, Signal Transduction

• Purification:

  Affinity purification

• Positive Control:

  293T

• Concentration:

  Batch dependent

• Buffer:

  PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

• Modification:

  None

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store at -20˚ C. Avoid freeze / thaw cycles.

• Calculated Molecular Weight:

  Observed: 68kDa

• Fragment:

  IgG

• Symbol:

  BCHE

• Positive Control 2:

  SW620

• NCBI Official Name:

  Butyrylcholinesterase

• NCBI Organism:

  Homo sapiens

• Other Product Names:

  BCHE, CHE1, E1, CHE2

• Tested Applications:

  WB, IHC, IF

• Physical Properties:

  Liquid